BRPI0307117B8 - amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos - Google Patents

amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos

Info

Publication number
BRPI0307117B8
BRPI0307117B8 BRPI0307117A BR0307117A BRPI0307117B8 BR PI0307117 B8 BRPI0307117 B8 BR PI0307117B8 BR PI0307117 A BRPI0307117 A BR PI0307117A BR 0307117 A BR0307117 A BR 0307117A BR PI0307117 B8 BRPI0307117 B8 BR PI0307117B8
Authority
BR
Brazil
Prior art keywords
cosmetic
derivatives
acid amides
active compounds
pharmaceutical active
Prior art date
Application number
BRPI0307117A
Other languages
English (en)
Portuguese (pt)
Other versions
BRPI0307117B1 (pt
BR0307117A (pt
Inventor
Sabater-Luentzel Christopher
Schmaus Gerhard
Joppe Holger
Herrmann Martina
Voessing Tobias
Original Assignee
Symrise Ag
Symrise Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32240379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0307117(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symrise Ag, Symrise Gmbh & Co Kg filed Critical Symrise Ag
Publication of BR0307117A publication Critical patent/BR0307117A/pt
Publication of BRPI0307117B1 publication Critical patent/BRPI0307117B1/pt
Publication of BRPI0307117B8 publication Critical patent/BRPI0307117B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0307117A 2002-11-25 2003-11-20 amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos BRPI0307117B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10254872.2 2002-11-25
DE10254872A DE10254872A1 (de) 2002-11-25 2002-11-25 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
PCT/EP2003/012990 WO2004047833A2 (de) 2002-11-25 2003-11-20 Anthranilsäureamide und deren derivate als kosmetische und pharmazeutische wirkstoffe

Publications (3)

Publication Number Publication Date
BR0307117A BR0307117A (pt) 2004-12-28
BRPI0307117B1 BRPI0307117B1 (pt) 2017-07-18
BRPI0307117B8 true BRPI0307117B8 (pt) 2021-05-25

Family

ID=32240379

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307117A BRPI0307117B8 (pt) 2002-11-25 2003-11-20 amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos

Country Status (9)

Country Link
US (2) US8203016B2 (enExample)
EP (1) EP1567143B1 (enExample)
JP (2) JP2006514931A (enExample)
KR (1) KR20050085127A (enExample)
CN (2) CN101683310B (enExample)
AU (1) AU2003288126A1 (enExample)
BR (1) BRPI0307117B8 (enExample)
DE (1) DE10254872A1 (enExample)
WO (1) WO2004047833A2 (enExample)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100274A1 (en) * 2004-11-05 2006-05-11 Trustees Of Tufts College Therapeutic avenanthramide compounds
SE0400234D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
ITMI20050674A1 (it) * 2005-04-15 2006-10-16 Univ Degli Studi Milano Uso di derivati ammidici come agenti modificatori del gusto composizioni aromatizzanti e prodotti che li contengono
WO2006134013A1 (en) * 2005-06-14 2006-12-21 Symrise Gmbh & Co. Kg Mixtures comprising anthranilic acid amides and cooling agents as cosmetic and pharmaceutical compositions for alleviating itching
US20070059268A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions, methods and kits for treating allergic dermatitis of skin
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
US20070185038A1 (en) * 2005-09-30 2007-08-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin care actives
WO2007062957A1 (en) 2005-11-30 2007-06-07 Symrise Gmbh & Co. Kg Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
EP1886662B1 (de) 2006-06-14 2014-04-09 Symrise AG Antimikrobiell wirksame Verbindungen zur Behandlung von Mundgeruch
PL2035369T3 (pl) * 2006-07-05 2015-02-27 Fibrotech Therapeutics Pty Ltd Związki terapeutyczne
NZ579040A (en) * 2007-02-06 2011-01-28 Chelsea Therapeutics Inc New compounds, methods for their preparation and use thereof
BRPI0810435A2 (pt) 2007-04-19 2014-11-25 Mary Kay Inc Composições contendo extrato de magnólia
WO2008131481A1 (en) * 2007-04-26 2008-11-06 Fibrotech Therapeutics Pty Ltd Treatment of mesangioproliferative diseases
EP2219637A4 (en) * 2007-11-08 2012-01-11 Ceapro Inc AVENANTHRAMIDE COMPOSITIONS
CN107162928B (zh) * 2007-12-21 2022-03-11 塞尔塔医疗有限公司 抗纤维化剂的卤代类似物
JP4979655B2 (ja) * 2008-08-07 2012-07-18 キヤノン株式会社 画像符号化装置及びその制御方法
US9533479B2 (en) * 2008-09-18 2017-01-03 Medline Industries, Inc. Absorbent articles having antimicrobial properties and methods of manufacturing the same
US10463891B2 (en) * 2008-09-30 2019-11-05 Symrise Ag Extracts of Isochrysis sp.
EP3348255B1 (en) * 2008-12-05 2021-11-10 Symrise AG Extracts of tetraselmis sp. for cosmetic and therapeutic purposes
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
CN102448450B (zh) 2009-04-09 2013-11-20 西姆莱斯有限公司 包含反式-叔丁基环己醇作为皮肤刺激缓解剂的组合物
EP2424829B1 (en) 2009-04-28 2015-01-07 Symrise AG Omega-cyclohexylalkan-1-oles and use thereof as antimicrobial actives to combat body odor
FR2945213B1 (fr) * 2009-05-07 2015-10-16 Rocher Yves Biolog Vegetale Compositions cosmetiques et dermatologiques et dermatologiques a base d'extrait de silene.
US9717818B2 (en) * 2009-05-08 2017-08-01 Medline Industries, Inc. Absorbent articles having antimicrobial properties and methods of manufacturing the same
EP2295031B1 (de) * 2009-08-05 2018-01-10 Symrise AG Verwendung von Pterocarpanen als Anti-Cellulite-Wirkstoffe
ATE537244T1 (de) * 2009-10-19 2011-12-15 Symrise Ag Riechstoffmischungen enthaltend isolongifolanol und moschus
ES2547309T3 (es) * 2009-10-19 2015-10-05 Symrise Ag Composiciones que contienen fragancias, que comprenden nonanoato de cetilo y/o nonanoato de estearilo
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
EP2158896A3 (de) 2009-11-02 2010-09-29 Symrise GmbH & Co. KG Riechstoffhaltige Zusammensetzungen umfassend Neopentylglycoldiisononanoat
EP2359702B1 (en) 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
JP5714694B2 (ja) 2010-04-08 2015-05-07 シムライズ アーゲー ジヒドロデヒドロジイソオイゲノールの使用およびジヒドロデヒドロジイソオイゲノールを含む製剤
EP2389922A1 (en) 2010-05-25 2011-11-30 Symrise AG Cyclohexyl carbamate compounds as anti-ageing actives
EP2286908A3 (de) 2010-11-19 2011-06-01 Symrise AG Lösungsvermittler für kosmetische Zubereitungen
EP2457554A1 (de) 2010-11-24 2012-05-30 Symrise AG Menthol enthaltende Mischung
EP2356977B1 (de) 2011-02-02 2017-12-27 Symrise AG Zubereitungen mit Holzextrakten von Gleditschien
EP2524959B1 (de) 2011-05-17 2014-01-22 Symrise AG Riech- und/oder Aromastoffkompositionen enthaltend Dioxolane
DE102011082464A1 (de) 2011-09-09 2011-12-01 Symrise Ag Riechstoffmischungen enthaltend bestimmte Isolongifolenylmethylether
EP2757905B1 (de) 2011-09-20 2015-08-19 Symrise AG Acetale und ketale als riech- und aromastoffe
EP2474301B1 (de) 2011-12-14 2014-04-16 Symrise AG Riechstoffmischungen enthaltend Cyclopent-2-Enyl-Essigsäureethylester
MY170724A (en) 2012-01-27 2019-08-27 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
WO2013133685A1 (en) 2012-03-09 2013-09-12 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
EP2861304B1 (en) 2012-06-15 2018-08-08 Symrise AG Compositions comprising hyaluronan biosynthesis promoting agents
EP2695597B1 (en) 2012-08-07 2019-07-24 Symrise AG Cosmetic compositions
WO2012143576A2 (en) 2012-08-23 2012-10-26 Symrise Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
EP2745878B1 (en) 2012-12-19 2023-01-25 Symrise AG Cosmetic compositions
WO2015180740A1 (en) * 2012-12-20 2015-12-03 Kao Germany Gmbh Oxidative dyeing composition
EP2764860A1 (en) 2013-02-06 2014-08-13 Basf Sa Cupuassu fatty acid amidoamines and their derivatives
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
EP2774604B1 (en) 2013-03-08 2017-08-30 Symrise AG Cosmetic compositions
ES2686046T3 (es) 2013-03-08 2018-10-16 Symrise Ag Composiciones antimicrobianas
EP2783578A1 (en) 2013-03-26 2014-10-01 Symrise AG Catechin reaction products
EP2789369B1 (en) 2013-04-14 2018-06-06 Symrise AG A composition for lightening skin and hair
US10188754B2 (en) 2013-05-16 2019-01-29 The Johns Hopkins University Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
EP2807925A1 (en) 2013-05-26 2014-12-03 Symrise AG Antimicrobial compositions
EP2810934A1 (en) 2013-06-09 2014-12-10 Symrise AG New succinate derivatives
EP2842607B1 (en) 2013-09-02 2018-05-30 Symrise AG A skin and/or hair whitening mixture
CN104418764B (zh) * 2013-09-11 2017-02-01 上海伊明化学科技有限公司 一种二氢燕麦酰基邻氨基苯甲酸d合成方法
EP3721944A1 (en) 2013-09-22 2020-10-14 Cutech S.R.L. Extracts of halimione portulacoides and their application
EP2853254B1 (en) 2013-09-26 2017-11-08 Symrise AG A composition for lightening skin and/or hair
EP2859883B1 (en) 2013-10-13 2019-05-15 Symrise AG Active mixtures comprising acylated oligopeptides and troxerutin
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
EP3062766A1 (en) 2013-10-29 2016-09-07 L'Oreal, S.A. Use of mono ornithine ketoglutarate (mokg)
AU2015229109B2 (en) 2014-03-14 2018-09-27 Gojo Industries, Inc. Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines
EP2962678A1 (en) 2014-06-30 2016-01-06 Symrise AG Flavour and fragrance compositions comprising acetophenone derivatives
EP2979682B1 (en) 2014-07-30 2018-09-05 Symrise AG A fragrance composition
EP3023090B1 (en) 2014-11-21 2019-08-07 Symrise AG Compositions
EP3045161A1 (en) 2015-01-18 2016-07-20 Symrise AG Active compositions comprising 1,2-hexanediol and 1,2-octanediol
EP3081207B1 (en) 2015-04-16 2022-09-21 Symrise AG Use of a liposome composition
US10391071B2 (en) 2015-04-28 2019-08-27 Cutech Srl Compositions comprising valerian extracts
EP3097905B1 (en) 2015-05-28 2020-11-04 Symrise AG Cosmetic compositions
EP3108941B1 (en) 2015-06-23 2018-05-09 Symrise AG Compositions comprising polyalkylene glycol derivatives
CN105078821A (zh) * 2015-08-14 2015-11-25 台山美环健芦荟制品有限公司 一种含芦荟鲜汁的抗刺激抗过敏产品及其制备方法
US11352587B2 (en) 2015-09-08 2022-06-07 Symrise Ag Fragrance mixtures
WO2017071752A1 (en) 2015-10-28 2017-05-04 Symrise Ag Method for inhibiting or masking fishy odours
KR102636229B1 (ko) 2015-11-15 2024-02-13 시므라이즈 아게 피부상의 쓰라림 (stining sensation) 경감
WO2017097434A1 (en) 2015-12-06 2017-06-15 Symrise Ag A fragrance composition
MX379850B (es) 2015-12-10 2025-03-11 Symrise Ag Composicion con sabor y olor estabilizado.
US11540987B2 (en) 2015-12-16 2023-01-03 Symrise Ag Composition with stabilized taste and odor (II)
ES2733201T3 (es) 2015-12-21 2019-11-28 Thiocyn Gmbh Composición cosmética que comprende una combinación de sustancias activas
EP3090727B8 (en) 2016-01-13 2019-06-19 Thiocyn GmbH Hair growth composition
CN109069378B (zh) 2016-02-15 2022-10-11 西姆莱斯股份公司 含有酯和酮的香料混合物
US11918679B2 (en) 2016-03-30 2024-03-05 Symrise Ag Active mixure
CN105902423A (zh) * 2016-04-15 2016-08-31 欧标（广州）化妆品有限公司 一种使皮肤色泽均匀及提亮肤色的美白面膜组合物
US11400035B2 (en) 2016-08-20 2022-08-02 Symrise Ag Preservative mixture
CN109642184A (zh) 2016-09-01 2019-04-16 西姆莱斯有限公司 包括塑料容器和物质组合物的产品
WO2018068825A1 (en) 2016-10-11 2018-04-19 Symrise Ag Antimicrobial compositions
WO2018099580A1 (en) 2016-12-01 2018-06-07 Symrise Ag Mixtures comprising phenyl alkanol and linear alcohol
EP3547991B1 (en) 2016-12-02 2025-06-11 Symrise AG Cosmetic blends
CN106631865A (zh) * 2016-12-19 2017-05-10 南京华狮新材料有限公司 一种燕麦生物碱及其衍生物的制备方法
MX2019009235A (es) 2017-02-03 2019-12-11 Certa Therapeutics Pty Ltd Compuestos antifibroticos.
JP6985409B2 (ja) 2017-03-21 2021-12-22 シムライズ アーゲー 着香剤および／またはフレーバリング剤としての５−ビシクロ［２．２．１］ヘプタ−２−エニル−アセテート
US10920170B2 (en) 2017-03-21 2021-02-16 Symrise Ag Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether
WO2018171871A1 (de) 2017-03-21 2018-09-27 Symrise Ag 2,3,6-trimethylcyclohexanol als riech- und/oder aromastoff
WO2018192652A1 (de) 2017-04-19 2018-10-25 Symrise Ag 1,1-dimeth/ethoxynon-3-in als riechstoff
US10745645B2 (en) 2017-04-21 2020-08-18 Symrise Ag 4-ethyl-octene-2/3-nitrile as a fragrance
WO2018196988A1 (de) 2017-04-28 2018-11-01 Symrise Ag Ethyl-2-acetyl-2,4-dimethyl-pent-4-enoat als riechstoff
IT201700090929A1 (it) 2017-08-07 2019-02-07 Cutech S R L Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea.
DE202017007679U1 (de) 2017-08-09 2024-03-15 Symrise Ag 1,2-Alkandiole
EP4331684A3 (en) 2017-08-09 2024-05-29 Symrise AG 1,2-alkanediols
CN107625680B (zh) * 2017-09-26 2020-07-10 杭州梵琳科技有限公司 舒敏水剂及其制备方法
EP3694474A1 (en) 2017-10-10 2020-08-19 Symrise AG Compositions containing benzoic acid or furoic acid derivatives and use of the derivatives for emulsion and foam stability
CN107868019A (zh) * 2017-11-09 2018-04-03 福州美乐莲生物科技有限公司 二氢燕麦生物碱类化合物、衍生物及其制备方法和应用
CN111479549B (zh) 2017-12-14 2023-09-12 西姆莱斯有限公司 含8,8-二甲基-6,10-二氧杂螺[4.5]癸烷的芳香物质混合物
WO2019166088A1 (en) 2018-02-28 2019-09-06 Symrise Ag Tetraselmis extract
WO2019166089A1 (en) 2018-02-28 2019-09-06 Symrise Ag Dermatological product
KR102562938B1 (ko) 2018-03-08 2023-08-02 시므라이즈 아게 인간 스킨 및/또는 헤어의 트리트먼트를 위한 단백질 추출물을 포함하는 혼합물들
WO2019180266A1 (en) 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
WO2019179639A1 (en) * 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
WO2018154145A2 (en) 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
CN112469685B (zh) 2018-07-23 2024-01-02 西姆莱斯股份公司 具有玫瑰气味的新型香味剂
US12193441B2 (en) 2018-08-27 2025-01-14 Symrise Ag Antimicrobial mixtures comprising at least one hydroxyphenone derivative
WO2020057761A1 (en) 2018-09-20 2020-03-26 Symrise Ag Compositions comprising odorless 1,2-pentanediol
KR102192624B1 (ko) * 2019-01-31 2020-12-17 경북대학교 산학협력단 아베난트라미드 c를 유효성분으로 포함하는 알레르기 질환 예방, 치료 또는 개선용 조성물
EP3938055A1 (en) 2019-03-12 2022-01-19 Symrise AG An antimicrobial mixture
US20220228085A1 (en) 2019-05-17 2022-07-21 Symrise Ag Fragrance or flavour mixture
WO2021008696A1 (de) 2019-07-16 2021-01-21 Symrise Ag Riechstoffmischung enthaltend 1,3-propandiol
CN110981925B (zh) * 2019-11-18 2021-05-25 福州百草堂医药科技有限公司 二氢燕麦生物碱d葡萄糖苷或其盐类化合物及其在化妆品中的应用
WO2021175452A1 (en) 2020-03-06 2021-09-10 Symrise Ag Composition comprising an avenanthramide or an analogue thereof with improved skin penetration
US20230129036A1 (en) 2020-03-06 2023-04-27 Symrise Ag Avenanthramide compositions with improved solubility comprising 4-hydroxyphenone
EP4114349A1 (en) * 2020-03-06 2023-01-11 Symrise AG Composition or oat extract comprising avenanthramide and beta-glucan
US20230131993A1 (en) * 2020-03-06 2023-04-27 Symrise Ag Composition comprising an avenanthramide or an analogue thereof with improved stability
BR112022017258A2 (pt) * 2020-03-06 2022-10-18 Symrise Ag Uso cosmético ou farmacêutico de avenantramida l
CN111302969A (zh) * 2020-04-08 2020-06-19 福建莲珂科技有限公司 邻氨基苯甲酸衍生物及其用途
US20230202963A1 (en) 2020-04-08 2023-06-29 Symrise Ag Esters as fragrance compounds
EP3944853A1 (en) 2020-07-31 2022-02-02 Basf Se Liquid l-menthol composition
US11369552B1 (en) 2020-09-11 2022-06-28 Elena Yurievna Komarova Aqueous nail polish remover
WO2022111793A1 (en) 2020-11-24 2022-06-02 Symrise Ag Medicament for accelerated wound healing
WO2022111829A1 (en) 2020-11-30 2022-06-02 Symrise Ag Essential oils of citrus fruits for use as medicament for induced, increased and/or accelerated autophagy in human keratinocytes
WO2022122122A1 (en) 2020-12-08 2022-06-16 Symrise Ag Medicament for fighting inflammatory conditions of human skin (i)
WO2022122140A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with active ingredients
WO2022122137A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising antimicrobials and (bio)-alkanediols for skin protection
WO2022122136A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with antioxidants
WO2022122134A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions with (bio)-alkanediols and cooling agents
WO2022122135A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising (bio)-alkanediols with antimicrobials for product protection
WO2022122131A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising lipophilic compounds and one or more (bio)-alkanediols
CN116490160A (zh) 2020-12-09 2023-07-25 西姆莱斯股份公司 一种含有1,2-链烷二醇的混合物
WO2022122133A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising uv-filters and one or more (bio)-alkanediols
WO2022122138A1 (en) 2020-12-09 2022-06-16 Symrise Ag Multifunctional compound mixtures comprising multiple (bio)-alkanediols
WO2022122132A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising natural polymers and one or more (bio)-alkanediols
WO2022122167A1 (en) 2020-12-11 2022-06-16 Symrise Ag Medicament for preventing or treating pathologic conditions of human skin (i)
WO2022128048A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for preventing or treating pathologic conditions of human skin
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue
WO2022128051A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (ii)
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)
WO2022128050A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammation and pain
WO2022128164A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
EP4259088A1 (en) 2020-12-14 2023-10-18 Symrise AG Cosmetic and/or pharmaceutical compositions containing cannabinoids
WO2022128052A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin
AU2021404384A1 (en) 2020-12-14 2023-06-29 Symrise Ag Extracts of isochrysis species / tisochrysis species
JP2024509365A (ja) 2021-02-12 2024-03-01 シムライズ アーゲー 色素沈着の予防及び治療のための医薬品
EP4373462A1 (en) 2021-07-23 2024-05-29 Symrise AG Compositions of dicaffeoylquinic acids with tocopherol
US12329704B2 (en) 2021-08-23 2025-06-17 Medline Industries, Lp Absorbent repositioning pad and method
WO2023036439A1 (en) 2021-09-13 2023-03-16 Symrise Ag Cyclopropanated fragrance compounds
WO2024027931A1 (en) 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
CN119604270A (zh) 2022-08-05 2025-03-11 西姆莱斯股份公司 包含抗微生物促进剂的组合物
WO2024027929A1 (en) 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
EP4565193A1 (en) 2022-08-05 2025-06-11 Symrise AG Composition with improved water resistance
CN119584951A (zh) 2022-08-05 2025-03-07 西姆莱斯股份公司 包含uv滤光剂稳定剂的组合物
CN119744164A (zh) 2022-08-05 2025-04-01 西姆莱斯股份公司 气味和着色剂稳定的组合物
WO2024027930A1 (en) 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent
WO2025031562A1 (en) 2023-08-04 2025-02-13 Symrise Ag Mycosporine-like amino acid analogue compounds and use thereof
CN119604267A (zh) 2022-08-05 2025-03-11 西姆莱斯股份公司 具有改进的spf和uva光防护的组合物
WO2024256011A1 (en) 2023-06-15 2024-12-19 Symrise Ag Stabilizer or stabilizer composition for stabilizing dihydroavenanthramide d
WO2025176314A1 (en) 2024-02-23 2025-08-28 Symrise Ag Liquid uv filter concentrate
WO2025176315A1 (en) 2024-02-23 2025-08-28 Symrise Ag Liquid uv filter composition containing diols
WO2025195570A1 (en) 2024-03-18 2025-09-25 Symrise Ag Dihydroavenanthramide d powder
WO2025195569A1 (en) 2024-03-18 2025-09-25 Symrise Ag Dihydroavenanthramide d for reducing fragrance degradation
CN119978040B (zh) * 2025-04-17 2025-07-18 上海际研生物医药开发有限公司 Hmgb1抑制剂、从火绒草提取物中靶向制备hmgb1抑制剂的方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126839B1 (enExample) 1970-01-16 1976-08-09
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
JPS5640710B2 (enExample) * 1973-01-18 1981-09-22
JPS5736905B2 (enExample) * 1974-04-17 1982-08-06
JPS5126839A (ja) * 1974-08-21 1976-03-05 Dainippon Pharmaceutical Co Benzuaniridojudotaino seizoho
US4347188A (en) * 1977-01-06 1982-08-31 Sumitomo Chemical Company, Limited N-Benzoylanthranilate derivatives
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JPS5736905A (ja) 1980-08-12 1982-02-27 Iseki Agricult Mach Naeishokuki
JPS5817186B2 (ja) * 1981-01-23 1983-04-05 キツセイ薬品工業株式会社 新規芳香族カルボン酸誘導体の製造方法
JPS5838444A (ja) 1981-08-29 1983-03-05 Shimadzu Corp クロマトグラフ質量分析計
JPS5838244A (ja) * 1981-09-01 1983-03-05 Kissei Pharmaceut Co Ltd 核置換シンナモイルアントラニル酸塩およびその製造方法
US4587356A (en) 1981-09-01 1986-05-06 Kissei Pharmaceutical Co., Ltd. Process for the production of nuclear substituted cinnamoylanthranilic acid derivatives
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
JPS60146856A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
JPH0733357B2 (ja) 1986-09-30 1995-04-12 日本レダリ−株式会社 ケイ皮酸誘導体
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
DD299424A5 (de) * 1989-05-23 1992-04-16 Sankyo Company Limited,Jp Phenolderivate zur foerderung des menschlichen nervenwachstumsfaktors
JPH08143525A (ja) * 1994-11-21 1996-06-04 Banyu Pharmaceut Co Ltd ヒドロキシ安息香酸アミド誘導体を有効成分とする骨疾患の予防・治療剤
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
JP3621483B2 (ja) * 1995-12-01 2005-02-16 花王株式会社 ヒスタミン遊離抑制剤
AU724646B2 (en) 1996-03-15 2000-09-28 Eli Lilly And Company Method of treating common cold or allergic rhinitis
ES2233394T3 (es) 1999-05-06 2005-06-16 Ceapro Inc. Composiciones que contienen avenantramida de extractos de avena.
JP4687837B2 (ja) 1999-09-29 2011-05-25 ライオン株式会社 眼科用組成物
JP4488560B2 (ja) 1999-10-26 2010-06-23 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral

Also Published As

Publication number Publication date
US8203016B2 (en) 2012-06-19
CN100548289C (zh) 2009-10-14
CN1713904A (zh) 2005-12-28
US20060089413A1 (en) 2006-04-27
US8409552B2 (en) 2013-04-02
JP2006514931A (ja) 2006-05-18
DE10254872A1 (de) 2004-06-03
AU2003288126A1 (en) 2004-06-18
WO2004047833A3 (de) 2005-01-13
EP1567143A2 (de) 2005-08-31
JP5467014B2 (ja) 2014-04-09
BRPI0307117B1 (pt) 2017-07-18
KR20050085127A (ko) 2005-08-29
BR0307117A (pt) 2004-12-28
WO2004047833A2 (de) 2004-06-10
CN101683310A (zh) 2010-03-31
CN101683310B (zh) 2012-12-12
EP1567143B1 (de) 2013-08-14
JP2010248268A (ja) 2010-11-04
US20120315233A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
BR0108678A (pt) Novos compostos
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ATE327977T1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
ECSP045410A (es) Nuevos derivados de piridazin-3(2h)-ona
UY27222A1 (es) Pirazolopirimidinas como agentes terapéuticos
BR0314393A (pt) Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia
BR0111667A (pt) Novos compostos
BR0314354A (pt) Formação para gentes lipofìlicos
BRPI0407430A (pt) Sal do ácido benzenossulfÈnico com clopidogrel, processos para preparação do mesmo, e para purificação de clopidogrel, uso de um sal, formulação farmacêutica, partìculas de substância ativa, uso de partìculas de substância ativa, e, processo para preparação de partìculas de substância ativa
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
BRPI0514750A (pt) derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase
WO2004100865A3 (en) New benzimidazole derivatives
BR9908702A (pt) Composto, processos para inibir sìntese de óxido nìtrico em um paciente, para inibir seletivamente sìntese de óxido nìtrico produzido pela no sintase indutìvel no óxido nìtrico produzido pelas formas constitutivas de no sintase em um paciente e para diminuir nìveis de óxido nìtrico em um paciente, e, composição farmacêutica
DE69904483D1 (de) Nitrat-salze als arzneimittel
BR0107770A (pt) Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas
BRPI0413094A (pt) derivados de quinolina e seu uso em terapia
TR200402342T4 (tr) 2-Pirindinil-6,7,8,9- Tetrahidropyrimido[1,2-A] Pirimidin-4-On ve 7-Pirindinil-1,3-Dihydoimidazo[1,2-A]Pirimidin-5(1H) on Türevleri
BR0313727A (pt) Derivados de isoquinolina como inibidores de metaloproteinase da matriz
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
ES2169886T3 (es) Derivados condensados de la piperidina como inhibidor de sintesis de monoxido de nitrogeno.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
BR0111669A (pt) Novos compostos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SYMRISE AG (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/11/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2801 DE 10/09/2024 POR TER SIDO INDEVIDA.